INHIBITION OF K+ CHANNELS BY CHLORPROMAZINE IN RAT VENTRICULAR MYOCYTES

被引:0
作者
KON, K
KRAUSE, E
GOGELEIN, H
机构
[1] HOECHST AG, SBU CARDIOVASC AGENTS, D-65926 FRANKFURT, GERMANY
[2] MAX PLANCK INST BIOPHYS, FRANKFURT, GERMANY
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Isolated rat ventricular myocytes were investigated with the whole-cell patch-clamp technique. Chlorpromazine inhibited inward-rectifying K+ currents (IC50 = 6.1 mu M), time-independent outward currents (IC50 = 16 mu M) and transient outward Kt currents. In the latter case, 100 mu M of chlorpromazine reduced the amplitude of the peak current recorded at a clamp potential of 50 mV from 2.14 +/- 0.59 nA to 1.38 +/- 0.20 nA (n = 4) and decreased the time course of fast inactivation from 8.29 +/- 1.17 msec to 4.01 +/- 0.90 msec (n = 4). In addition, chlorpromazine blocked the ATP-dependent K+ current, which was activated either by the channel opener rilmakalim (10 mu M) or by metabolic inhibition with carbonyl cyanide p-trifluoromethoxyphenylhydrazone (FCCP, 500 nM; IC50 for rilmakalim = 2.5 mu M; IC50 for FCCP = 11.5 mu M). The drug caused marked depolarization of the resting potential at higher concentrations (50 mu M) from -79 +/- 3 mV to -27 +/- 11 mV (n = 4). The reversibility from channel block was slow and only partial for time-independent currents, especially inward-rectifying K+ currents, but it was relatively fast and complete for time-dependent currents. Thus chlorpromazine blocks a variety of K+ channels in heart muscle cells. Inasmuch as the potency of inhibition is less than the previously reported use-dependent block of Na+ channels, the cardiovascular adverse effects of chlorpromazine are probably caused mainly by the latter effect.
引用
收藏
页码:632 / 637
页数:6
相关论文
共 36 条
[1]   CHARACTERIZATION OF 2 DISTINCT DEPOLARIZATION-ACTIVATED K+ CURRENTS IN ISOLATED ADULT-RAT VENTRICULAR MYOCYTES [J].
APKON, M ;
NERBONNE, JM .
JOURNAL OF GENERAL PHYSIOLOGY, 1991, 97 (05) :973-1011
[2]  
ARITA M, 1973, J PHARMACOL EXP THER, V184, P619
[3]   INACTIVATION OF SODIUM CHANNEL .1. SODIUM CURRENT EXPERIMENTS [J].
BEZANILLA, F ;
ARMSTRONG, CM .
JOURNAL OF GENERAL PHYSIOLOGY, 1977, 70 (05) :549-566
[4]   THE EFFECTS OF THE ATP-DEPENDENT POTASSIUM CHANNEL ANTAGONIST, GLYBURIDE, ON CORONARY BLOOD-FLOW AND SUSCEPTIBILITY TO VENTRICULAR-FIBRILLATION IN UNANESTHETIZED DOGS [J].
BILLMAN, GE ;
AVENDANO, CE ;
HALLIWILL, JR ;
BURROUGHS, JM .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1993, 21 (02) :197-204
[5]  
CASTLE NA, 1990, J PHARMACOL EXP THER, V255, P1038
[6]  
Cooper T B, 1976, Int Rev Neurobiol, V19, P269, DOI 10.1016/S0074-7742(08)60706-0
[7]   NEUROLEPTICS DECREASE CALCIUM-ACTIVATED POTASSIUM CONDUCTANCE IN HIPPOCAMPAL PYRAMIDAL CELLS [J].
DINAN, TG ;
CRUNELLI, V ;
KELLY, JS .
BRAIN RESEARCH, 1987, 407 (01) :159-162
[8]   AIRWAY PHARMACOLOGY OF THE POTASSIUM CHANNEL OPENER, HOE-234, IN GUINEA-PIGS - INVITRO AND INVIVO STUDIES [J].
ENGLERT, HC ;
WIRTH, K ;
GEHRING, D ;
FURST, U ;
ALBUS, U ;
SCHOLZ, W ;
ROSENKRANZ, B ;
SCHOLKENS, BA .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 210 (01) :69-75
[9]   COMPARISON BETWEEN THE ACTIVITIES OF CATIONIC AMPHIPHILIC DRUGS TO AFFECT PHOSPHOLIPID-MEMBRANES AND TO DEPRESS CARDIAC-FUNCTION [J].
GIRKE, S ;
MOHR, K ;
SCHRAPE, S .
BIOCHEMICAL PHARMACOLOGY, 1989, 38 (15) :2487-2496
[10]   MECHANISMS OF EXCITATION CONTRACTION COUPLING FAILURE DURING METABOLIC INHIBITION IN GUINEA-PIG VENTRICULAR MYOCYTES [J].
GOLDHABER, JI ;
PARKER, JM ;
WEISS, JN .
JOURNAL OF PHYSIOLOGY-LONDON, 1991, 443 :371-386